MDS Virtual Congress 2021 Archives - Page 38 of 132

Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease

H. Jackson, J. Anzures-Cabrera, T. Simuni, R. Postuma, G. Pagano (Welwyn Garden City, United Kingdom)
Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)
Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson’s disease.

J. Pagonabarraga, R. Pérez-González, H. Bejr-Kasem, A. Horta-Barba, I. Aracil-Bolaños, S. Martinez-Horta, E. Rivas-Asensio, J. Perez-Perez, F. Sampedro, A. Campolongo, C. Izquierdo, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)
Distinct cholinergic reactivity to dopamine is related with differed parkinsonian tremor responsiveness

J. Wu, C. Zhou, T. Guo, X. Guan, X. Bai, H. Wu, J. Chen, J. Wen, X. Liu, P. Huang, X. Xu, M. Zhang (Hangzhou, China)
Distinct impulsive traits in cerebellar ataxia and Parkinson’s disease

T. Chen, C. Lin, M. Aumann, D. Claassen, S. Kuo (New York, USA)
Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE

G. Coughlan, P. Mclaughlin, K. Sunderland, M. Borrie, C. Fischer, A. Frank, M. Freedman, S. Kumar, S. Pasternak, B. Pollock, T. Rajji, D. Seitz, D. Tang-Wai, C. Tartaglia, J. Dewar, D. Kwan, B. Tan, D. Grimes, M. Jog, T. Lang, C. Marras, T. Steeves, D. Bulman, A. Dilliott, M. Ghani, R. Hegele, J. Robinson, E. Rogaeva, S. Farhan, R. Bartha, N. Nanayakkara, J. Ramirez, C. Scott, S. Symons, C. Berezuk, M. Holmes, S. Adamo, M. Ozzoude, A. Theyers, S. Arnott, D. Beaton, W. Lou, S. Sujanthan, B. Levine, J. Orange, A. Peltsch, A. Roberts, A. Troyer, M. Binns, S. Black, S. Strother, M. Moscovitch, C. Grady, M. Masellis (Toronto, Canada)
Distinct oscillatory fingerprints in dyskinesias mediated by D1 versus D2 receptors

K. Skovgård, P. Halje, SA. Barrientos, P. Petersson, MA. Cenci (Lund, Sweden)
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

L. Andreoli, M. Abbaszadeh, X. Cao, A. Cenci Nilsson (Lund, Sweden)
DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)